Fyodor Urnov

Fyodor Urnov is a Professor of Molecular Therapeutics at the University of California, Berkeley, in the Department of BIO. His research focuses on the development and advancement to the clinic of CRISPR-Cas-based genome and epigenome editing approaches for Mendelian, neurodegenerative, neuroinflammatory, and infectious diseases. His work includes projects related to inborn errors of immunity, Huntington's disease, and virus-induced leukoencephalopathy, among others. He is also the Director for Technology and Translation at the IGI.

Fyodor Urnov is a researcher at the University of California, Berkeley, and the Innovative Genomics Institute, focusing on genome and epigenome editing for disease treatment. His work involves the development and application of genome editing technologies, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR-based systems, to correct genetic mutations and treat diseases. Urnov's research spans human pluripotent cells, HIV-1 resistance, and gene editing in model organisms like zebrafish and rats. His contributions include advancing precise genome modification in crops and human stem cells, with a focus on therapeutic applications.